BRIDGER MANAGEMENT, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGER MANAGEMENT, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2019$38,554,000
-7.4%
1,083,598
-12.5%
3.03%
-8.1%
Q1 2019$41,613,000
+11.6%
1,238,489
+9.2%
3.29%
+6.0%
Q4 2018$37,288,000
-46.1%
1,134,4140.0%3.11%
-22.3%
Q3 2018$69,154,000
+24.8%
1,134,4140.0%4.00%
+33.3%
Q2 2018$55,393,000
-22.0%
1,134,414
+69.7%
3.00%
-30.3%
Q1 2018$71,034,000
-13.0%
668,492
-51.1%
4.31%
-20.1%
Q4 2017$81,647,000
+49.6%
1,367,171
-39.9%
5.39%
+64.9%
Q3 2017$54,592,000
-0.7%
2,274,661
-19.1%
3.27%
+4.2%
Q2 2017$54,957,000
-20.3%
2,811,092
-4.3%
3.14%
-20.3%
Q1 2017$68,937,000
+42.4%
2,937,255
-25.5%
3.93%
+16.9%
Q4 2016$48,401,000
-0.5%
3,944,692
+39.3%
3.36%
+2.6%
Q3 2016$48,665,000
-5.0%
2,832,636
-21.3%
3.28%
-0.8%
Q2 2016$51,207,000
+5.9%
3,598,554
+2.3%
3.31%
-1.0%
Q1 2016$48,359,000
+83.5%
3,517,011
+124.9%
3.34%
+283.7%
Q4 2015$26,351,0001,563,8620.87%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders